Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.

Miyazato, Yusuke; Yamamoto, Kei; Yamada, Gen; Kubota, Shuji; Ishikane, Masahiro; Sugiyama, Masaya; Ueno, Mikako; Matsunaga, Akihiro; Miyoshi-Akiyama, Tohru; Ishizaka, Yukihito; Ohmagari, Norio

Miyazato, Yusuke; Yamamoto, Kei; Yamada, Gen; Kubota, Shuji; Ishikane, Masahiro; Sugiyama, Masaya; Ueno, Mikako; Matsunaga, Akihiro; Miyoshi-Akiyama, Tohru; Ishizaka, Yukihito; Ohmagari, Norio.

Emerg Infect Dis ; 28(4): 870-872, 2022 04.

Article en En | MEDLINE | ID: mdl-35148495

ABSTRACT

ABSTRACT

A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem inflammatory syndrome. COVID-19 vaccination could be a trigger for this condition.

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Adulto; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Humanos; Masculino; SARS-CoV-2; Vacunas Sintéticas; Vacunas de ARNm

Palabras clave

COVID-19; Japan; MIS-A; SARS-CoV-2; anti-nucleocapsid antibody; anti-spike antibody; coronavirus disease; cytokine profile; hyperinflammatory state; multisystem inflammatory syndrome; myocardial injury; respiratory failure; severe acute respiratory syndrome coronavirus 2; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Idioma: En Revista: Emerg Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google